Autoimmune response and its long-term consequences after exon-skipping therapy in a Duchenne muscular dystrophy mouse model
{{output}}
The progress of antisense-based therapies using first generation Morpholino oligonucleotides for Duchenne muscular dystrophy (DMD) is expected to partially restore dystrophin expression and may prolong the lifespan of DMD patients. In a recent issue of The Jou... ...
